Product NDC: | 42291-311 |
Proprietary Name: | Guanfacine Hydrochloride |
Non Proprietary Name: | Guanfacine Hydrochloride |
Active Ingredient(s): | 2 mg/1 & nbsp; Guanfacine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42291-311 |
Labeler Name: | AvKARE, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075109 |
Marketing Category: | ANDA |
Start Marketing Date: | 19981125 |
Package NDC: | 42291-311-90 |
Package Description: | 90 TABLET in 1 BOTTLE (42291-311-90) |
NDC Code | 42291-311-90 |
Proprietary Name | Guanfacine Hydrochloride |
Package Description | 90 TABLET in 1 BOTTLE (42291-311-90) |
Product NDC | 42291-311 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Guanfacine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19981125 |
Marketing Category Name | ANDA |
Labeler Name | AvKARE, Inc. |
Substance Name | GUANFACINE HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |